Navigation Links
Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years

y, which was maintained over 5.5 years for both virus types 16 and 18. At the end of the 5.5 year observation period, the average level of antibodies against both virus types 16 and 18 was at least 11 times greater than antibody levels associated with natural infection with the virus.

"The results of this study confirm our confidence in our cervical cancer candidate vaccine, which includes a novel proprietary adjuvant system, called AS04, intended to enhance immune response and increase duration of protection," said Dr. Hugues Bogaerts, Vice President of Worldwide Medical Affairs, Human Papillomavirus Vaccines, GSK. "We believe that the best possible prevention of cervical cancer will include routine screening together with a vaccine designed to provide broad and durable protection against the most common cancer-causing virus types."

Notes to editors

About the study

This was an extended follow-up (EFU) analysis of women who participated in the initial efficacy study of GSK's cervical cancer candidate vaccine. The initial study was a double-blind, controlled trial of 1,113 young women between 15-25 years of age, randomized to receive three doses of the GSK candidate vaccine for cervical cancer formulated with the AS04 adjuvant system, or three doses of placebo on a 0, 1 and 6 month schedule.

This extended follow-up study looked at study endpoints for 776 women from the same cohort of women for a period of up to 67 months. The trial was conducted in 28 centers in Brazil, Canada and the U.S. and evaluated the efficacy, safety and immunogenicity of GSK's cervical cancer candidate vaccine for the prevention of infection with cancer causing virus types 16 and/or 18, and other cancer-causing virus types, as well as associated Pap smear abnormalities and cervical precancerous lesions. In the extended follow up study, women were evaluated for the presence of human papillomavirus DNA by PCR using cervical samples and annual cervical cytology
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
2. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
5. Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia
6. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
Post Your Comments:
(Date:8/18/2008)... BETHESDA, Md., Aug. 18 /...ical company developing novel, proprietary,antibod...autoimmune,diseases, will host a webcast and confe...at 10:00 a.m. Eastern Time (4:00 p.m. Central Euro...ere published in the Journal,SCIENCE on August 15,...
(Date:8/14/2008)... PRINCETON, N.J., Aug. 14 /PRNewswire-FirstCall/...stage pharmaceutical company committed to,discover... treat viral,infections, reported unaudited financ...e 30, 2008. Pharmasset reported a net loss attribu...a loss per share of $0.69 for the,quarter ended Ju...
(Date:8/13/2008)... Provides risk managers with comprehensive overvi...posure and required coverage, CHICAGO, Aug. 13 /P...,technology arm of Aon Corporation (NYSE: AOC ) a...ce solutions, today announced it has launched a ne...he market-leading,browser-based risk management i...
(Date:8/13/2008)... Reduction of CRP with ISIS 353512 could provide ...renal and inflammatory diseases, CARLSBAD, Calif....ticals, Inc. (Nasdaq: ISIS ) announced today it h...tisense drug that inhibits the,production of C-rea...vated,in patients with a variety of diseases inclu...
Breaking Medicine Technology:Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Aon eSolutions Launches Clinical Trials Module 2Aon eSolutions Launches Clinical Trials Module 3Aon eSolutions Launches Clinical Trials Module 4Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3WuXi PharmaTech 28NYSE 3A WX 29 Promotes Edward Hu to COO 2442 1WuXi PharmaTech 28NYSE 3A WX 29 Promotes Edward Hu to COO 2442 2Pharmos Corporation Announces Board and Management Changes 2440 1Pharmos Corporation Announces Board and Management Changes 2440 2Pharmos Corporation Announces Board and Management Changes 2440 3Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 1Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 2Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 3Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 1Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 2Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 3Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 4
...ss.--(BUSINESS WIRE)--Mar 14, 2007 - ArQule, Inc.,...ociety of,Clinical Oncology (ASCO) has accepted fo... 197 (A Phase 1 Dose Escalation Study of,ARQ 197, ...ients,with Metastatic Solid Tumors) at the 43rd AS...s presentation will describe findings,from a Phase...
...lough Announces Presentation Of Phase II Trial Res...t The 2007 Annual,Meeting Of The American College ...6, 2007 /PRNewswire-FirstCall/ --,Schering-Plough ...ase II trial of its novel oral thrombin receptor a...e 2007 annual Scientific Sessions,of the of Cardio...
Other Medicine Technology:ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4Media Advisory: ACC Updated Schedule 2
(Date:8/20/2008)...usetts General Hospital (MGH) investigators have f...em cell appeared to protect gastrointestinal tissu...ir report published in the journal Stem Cells , t...icine report that mesenchymal stem cells (MSCs), k...allowed the regeneration of the gastrointestinal l...
(Date:8/20/2008)...NGTON, Aug. 20 /PRNewswire-USNewswire/ -- Yesterda... admitted to Huron Hospital after,suffering an ane...Ohio. At,the present time Rep. Tubbs Jones, condit...are available., Tuesday,s condition followed a fu...ming forum on electoral reform, scheduled for Sept...
(Date:8/20/2008)... Micro(R) PUMP and ELLEgirl.com Send Four Girls to...Summer, LOS ANGELES, Aug. 20 /PRNewswire/ -- Reti...eenage Web site ELLEgirl.com to send four contest,...Camp in Santa Monica,California. With the new sch...mpower girls to become successful women by helping...
(Date:8/20/2008)...IEGO, Aug. 20 /PRNewswire/ --You,re late for work,...r car won,t start. How do you deal with,the rising...ash out in,frustration, how you deal with anger af...r children and even your career., As hard as we m...push,our buttons. While feeling anger isn,t a bad ...
Breaking Medicine News(10 mins):Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 2Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 4Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 5Health News:Taming Your Temper: Learning to Turn Down the Heat 2
...oLipo(TM) laser module received clearance from the...ted lipolysis, and its BBL(TM) broadband pulsed li...les. ProLipo represents the latest technological ...ber-delivered laser energy to target fatty tissue....
... food for its 2.3 million soldiers, with the milit... recent spate of health scandals, state media rep...e or substandard food products and eliminating the... eating from the same plate, according to an annou...
...r a day, the Australian police finally announced t... in southern India, was being charged with provid...em a mobile phone SIM card. His cousin Sabeel Ahm... in Runcorn, southeast of Liverpool, has been accu...
... registry of pregnancies and abortions to stem sel... according to a report. India has only 927 femal...ldwide average of 1,050 females -- mainly due to s...e country where many people prefer to have male ch...
Other Medicine News:Health News:Sciton Receives FDA Clearance for Lipolysis and Wrinkle Treatment 2Health News:Three Doctors Charged So Far in the UK Bombing Case 2Health News:Three Doctors Charged So Far in the UK Bombing Case 3Health News:Three Doctors Charged So Far in the UK Bombing Case 4Health News:India to Monitor Pregnancies to Check Girl Foeticide: Report 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: